Edoardo Crimini

6PUBLICATIONS
54CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsLiquid biopsiesCancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Feb 26, 2026
Harnessing Vaccines in the Treatment of Solid Tumors: Advances, Challenges, and Future Directions.

Jorge Iranzo, Edoardo Giordano, Renato Maria Marsicano

|Sep 30, 2025
Genomically matched therapy in advanced solid tumors: the randomized phase 2 ROME trial.

Paolo Marchetti, Giuseppe Curigliano, Mauro Biffoni

|Aug 20, 2025
The Impact of Concordance between Liquid and Tissue Biopsy for Actionable Mutations: Insights from the ROME Trial.

Andrea Botticelli, Chiara Cremolini, Simone Scagnoli

|Jul 05, 2024
Trastuzumab-deruxtecan in solid tumors with HER2 alterations: from early phase development to the first agnostic approval of an antibody-drug conjugate.

Crimini Edoardo, Curigliano Giuseppe

|Jan 23, 2024
Beyond PD(L)-1 Blockade in Microsatellite-Instable Cancers: Current Landscape of Immune Co-Inhibitory Receptor Targeting.

Edoardo Crimini, Luca Boscolo Bielo, Pier Paolo Maria Berton Giachetti

|May 25, 2022
The return of RET GateKeeper mutations? an in-silico exploratory analysis of potential resistance mechanisms to novel RET macrocyclic inhibitor TPX-0046.

Matteo Repetto, Edoardo Crimini, Liliana Ascione

Pageof 1

Frequent Collaborators

5 joint publications

Giuseppe Curigliano

2 joint publications

Pier Paolo Maria Berton Giachetti

2 joint publications

Pierfranco Conte

2 joint publications

Carmen Belli